<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-07-12">12 July 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Legge</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hamshere</surname></persName>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Ripke</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Pardinas</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Goldstein</surname></persName>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Rees</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Richards</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Leonenko</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Jorskog</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Clozapine-Induced</forename><forename type="middle">Agranulocytosis</forename><surname>Consortium</surname></persName>
						</author>
						<author>
							<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Chambert</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Collier</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Genovese</surname></persName>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Giegling</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Holmans</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Jonasdottir</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Kirov</surname></persName>
						</author>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Mccarroll</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Maccabe</surname></persName>
						</author>
						<author>
							<persName><forename type="first">K</forename><surname>Mantripragada</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Moran</surname></persName>
						</author>
						<author>
							<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Neale</surname></persName>
						</author>
						<author>
							<persName><forename type="first">H</forename><surname>Stefansson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Rujescu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Daly</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Sullivan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Owen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>O'donovan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jtr</forename><surname>Walters</surname></persName>
						</author>
						<title level="a" type="main">Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-07-12">12 July 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">75B7CE1388708098577DC723D693926E</idno>
					<idno type="DOI">10.1038/mp.2016.97</idno>
					<note type="submission">Received 21 January 2016; revised 10 May 2016; accepted 17 May 2016;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The antipsychotic clozapine is uniquely effective in the management of schizophrenia; however, its use is limited by its potential to induce agranulocytosis.</s><s>The causes of this, and of its precursor neutropenia, are largely unknown, although genetic factors have an important role.</s><s>We sought risk alleles for clozapine-associated neutropenia in a sample of 66 cases and 5583 clozapine-treated controls, through a genome-wide association study (GWAS), imputed human leukocyte antigen (HLA) alleles, exome array and copy-number variation (CNV) analyses.</s><s>We then combined associated variants in a meta-analysis with data from the Clozapine-Induced Agranulocytosis Consortium (up to 163 cases and 7970 controls).</s><s>In the largest combined sample to date, we identified a novel association with rs149104283 (odds ratio (OR) = 4.32, P = 1.79 × 10 − 8 ), intronic to transcripts of SLCO1B3 and SLCO1B7, members of a family of hepatic transporter genes previously implicated in adverse drug reactions including simvastatin-induced myopathy and docetaxel-induced neutropenia.</s><s>Exome array analysis identified gene-wide associations of uncommon non-synonymous variants within UBAP2 and STARD9.</s><s>We additionally provide independent replication of a previously identified variant in HLA-DQB1 (OR = 15.6,</s><s>P = 0.015, positive predictive value = 35.1%).</s><s>These results implicate biological pathways through which clozapine may act to cause this serious adverse effect.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Clozapine is the only licensed medication for treatment-resistant schizophrenia, defined as a failure to respond to at least two antipsychotic trials of sufficient dose and duration.</s><s>Although it is the only treatment with proven efficacy in this severely impaired group of patients, <ref type="bibr" target="#b9">1,</ref><ref type="bibr" target="#b10">2</ref> it is substantially under-prescribed <ref type="bibr" target="#b11">3</ref> due, at least in part, to the risk of haematological side effects of agranulocytosis and neutropenia (that is, reductions of neutrophils to levels below 500 or 1500 mm −3 , respectively).</s><s>The cumulative risk of agranulocytosis in those taking clozapine is 0.8% and for neutropenia is 2.9%. <ref type="bibr" target="#b12">4</ref> If undetected, compromised immune function secondary to agranulocytosis can be fatal, as happened in a series of patients when the drug was introduced in the 1970s, leading to its widespread withdrawal.</s><s>Evidence of its marked effectiveness over other antipsychotics led to Federal Drug Agency (USA) approval in 1989 with stipulations about the need for regular blood monitoring to aid early detection of blood abnormalities.</s><s>The requirement for blood monitoring limits the acceptability of the drug to patients, and poses an obstacle to its use in clinical practice. <ref type="bibr" target="#b13">5</ref></s><s>he aetiology of clozapine-induced blood disorders is currently unknown, although genetic causes contribute.</s><s>The first genomewide association study (GWAS) conducted by the Clozapine-Induced Agranulocytosis Consortium (CIAC) has provided substantial evidence for the role of HLA-DQB1 and HLA-B in clozapine-associated neutropenia. <ref type="bibr" target="#b14">6</ref></s><s>In this study we report analyses incorporating GWAS, human leukocyte antigen (HLA) allele imputation, exome array and copy-number variation (CNV) to examine genetic associations with clozapine-associated neutropenia.</s><s>Associated variants were combined in a joint meta-analysis with data from the CIAC study, <ref type="bibr" target="#b14">6</ref> giving the largest combined study sample of its kind to date.</s><s>E-mail: WaltersJT@Cardiff.ac.uk schizophrenia. <ref type="bibr" target="#b15">7</ref></s><s>CLOZUK comprises individuals who were prescribed clozapine in the United Kingdom and have a clinical diagnosis of treatment-resistant schizophrenia. <ref type="bibr" target="#b15">7,</ref><ref type="bibr" target="#b16">8</ref></s><s>The CLOZUK samples were acquired anonymously by the research team, in accordance with ethics permissions and the UK Human Tissue Act, in collaboration with Novartis, one of the UK suppliers of clozapine.</s><s>Twelve months after sample acquisition, the research team was informed of those who had developed neutropenia while taking clozapine and, where available, the recorded lowest neutrophil counts of these individuals were supplied.</s><s>CardiffCOGS is a schizophrenia sample recruited from secondary mental health services in South Wales, UK; for detailed sample description see. <ref type="bibr" target="#b16">8,</ref><ref type="bibr" target="#b17">9</ref></s><s>As part of a comprehensive clinical interview, individuals were asked about lifetime clozapine use and occurrence of neutropenia.</s><s>Clinical case notes were used to confirm neutropenia status, and lowest recorded neutrophil levels were collected.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sample description</head><p><s>Clozapine-associated neutropenia cases (n = 66) developed an absolute neutrophil count (ANC) ⩽ 1500 mm −3 during treatment with clozapine.</s><s>Following the approach of recent studies, <ref type="bibr" target="#b14">6,</ref><ref type="bibr" target="#b18">10</ref> we assessed cases with neutropenia because the success of the monitoring system and preemptive drug withdrawal in the United Kingdom has made agranulocytosis extremely rare.</s><s>This neutrophil count threshold is used in the United Kingdom as a trigger to discontinue clozapine.</s><s>Controls (n = 5583) had received clozapine for a minimum of a year without developing an ANC o2000 mm −3 .</s><s>Those who had a test result (1500 mm −3 oANCo2000 mm −3 ) were excluded from all analyses (n = 20).</s><s>No differences in age or sex were observed between clozapine-associated neutropenia cases and controls (Supplementary Table <ref type="table" target="#tab_0">1</ref>).</s><s>All individuals were of European ancestry, as determined by self-report and principal component analysis (PCA) of GWAS data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genotyping</head><p><s>Genotyping was performed at the Broad Institute, Cambridge, MA, USA.</s><s>CardiffCOGS and part of the CLOZUK sample (40 cases and 3573 controls) were genotyped on Illumina HumanOmniExpressExome-8v1 and the remainder of the CLOZUK sample (26 cases and 2098 controls) were genotyped on both Illumina HumanOmniExpress-12v1 and Illumina HumanExome BeadChip (San Diego, CA, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genome-wide association study</head><p><s>Quality-control procedures and imputation were conducted using the Psychiatric Genomics Consortium pipeline. <ref type="bibr" target="#b15">7</ref></s><s>Imputation was performed using IMPUTE2 (ref.</s><s><ref type="figure" target="#fig_1">11</ref>) and a reference panel from the full 1000 Genomes Project data set (freeze date August 2012, see Supplementary Methods).</s><s>Principal component estimation was conducted using EIGENSTRAT to exclude outliers and assess population stratification <ref type="bibr" target="#b20">12</ref> (Supplementary Figures <ref type="figure" target="#fig_2">1 and 2</ref>).</s><s>We included genotyping array as well as the first three principal components as covariates to account for population structure.</s><s>Single-nucleotide polymorphisms (SNPs) with allele frequencies that differed between genotyping arrays at Po1 × 10 − 5 were excluded (Supplementary Figure <ref type="figure">3</ref>).</s><s>We selected common SNPs for analysis with high imputation quality (imputation INFO score ≥ 0.8, minor allele frequency (MAF) ≥ 0.01 in cases and controls).</s><s>Association analysis was performed using logistic regression in PLINK <ref type="bibr" target="#b21">13</ref> and SNPs functionally annotated using the Scripps genome advisor. <ref type="bibr" target="#b22">14</ref></s><s>PLINK <ref type="bibr" target="#b21">13</ref> was used to identify index SNPs in relative linkage equilibrium.</s><s>Further details of quality-control procedures and statistical analyses are provided in Supplementary Methods.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HLA analysis</head><p><s>Classical HLA alleles and amino-acid polymorphisms were imputed using SNP2HLA (version 1.02) <ref type="bibr" target="#b23">15</ref> using BEAGLE (version 3.0.4) <ref type="bibr" target="#b24">16</ref></s><s>from genotyped common variants using a reference data set of 5225 individuals from Type 1 Diabetes Genetics Consortium (T1DGC).</s><s>We used the same procedures for SNP selection, analysis and covariate selection (three PCAs derived from GWAS, plus genotyping array) as described for the GWAS analysis above.</s><s>Owing to complex and extended linkage disequilibrium (LD) in the major histocompatibility complex, we did not identify index SNPs in relative linkage equilibrium.</s></p><p><s>We additionally genotyped a candidate SNP, HLA-DQB1 6672G4C (ref.</s><s>17; rs113332494) in 60 cases and 305 age-and sex-matched controls.</s><s>This SNP was genotyped separately as it was not imputed with sufficient quality to be reported in the GWAS or HLA analyses, and was a strong candidate variant. <ref type="bibr" target="#b25">17</ref></s><s>Genotyping was conducted at deCODE genetics using the Centaurus (Nanogen) platform. <ref type="bibr" target="#b26">18</ref></s><s>Association with clozapine-associated neutropenia was tested using Fisher's exact test, given low minor allele counts; however, to ensure there was no effect of population stratification, we also conducted a logistic regression including three PCAs derived from GWAS with 5 × 10 8 permutations to generate empirical P-values.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Exome array analysis</head><p><s>The Illumina exome array is designed to genotype uncommon-to-rare coding variants previously observed in whole-exome sequencing studies.</s><s>Exome array data were available for 57 cases and 4958 exposed controls.</s><s>Full details of the quality-control procedures are provided in an open access publication <ref type="bibr" target="#b27">19</ref> and Supplementary Methods.</s><s>PCA was conducted using EIGENSTRAT, <ref type="bibr" target="#b20">12</ref> with 14 743 common exome array variants in relative linkage equilibrium (MAF ⩾ 0.05, r 2 o0.2) to assess population structure and identify outliers (Supplementary Figure <ref type="figure">4</ref>).</s><s>Owing to the relatively small case sample size in our study we did not apply a frequency filter to variants in this analysis.</s><s>Single variant association was conducted using logistic regression in PLINK with the first 10 principal components included as covariates.</s><s>Adaptive permutations (between 10 and 1 × 10 9 ) were used to generate empirical P-values in logistic regression analyses.</s><s>PLINK <ref type="bibr" target="#b21">13</ref> was used to identify index SNPs in relative linkage equilibrium.</s><s>To test for the effects of multiple functional variants in genes, we used SKAT-O (ref.</s><s>20) with 2 × 10 6 permutations, including the first 10 principal components, for genes with at least two uncommon (MAFo0.05),</s><s>non-synonymous (missense, stop or splice) variants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Copy-number variation</head><p><s>The identification and quality control of CNV for this sample has been previously described <ref type="bibr" target="#b16">8</ref> and is detailed in Supplementary Methods.</s><s>CNVs were included if they had a frequency ⩽ 0.01, contained ⩾ 10 probes and were ⩾ 100 kb in length.</s><s>Samples that passed both CNV and GWAS quality control (63 cases and 5456 controls) were used to test genes for enrichment of exon disrupting CNVs using a two-sided Fisher's exact test.</s><s>Deletions and duplications were analysed separately.</s></p><p><s>Secondary analysis of clozapine-associated neutropenia below ⩽ 1000 mm <ref type="bibr">−3</ref> We conducted secondary analyses on a subset of the more severely affected cases with ANC ⩽ 1000 mm −3 (n = 18).</s><s>A total of four of these cases had developed agranulocytosis (ANC ⩽ 500 mm − 3 ).</s><s>We assessed the association of single variants with clozapine-associated neutropenia below ⩽ 1000 mm −3 in GWAS (N = 18), exome array (N = 16) and HLA imputation (N = 18) analyses.</s><s>All analyses conducted were consistent with methods used for clozapine-associated neutropenia, described above.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Replication sample and meta-analysis</head><p><s>We obtained summary statistics for associated SNPs from a recently published study by the CIAC. <ref type="bibr" target="#b14">6</ref></s><s>In this study, Goldstein et al. <ref type="bibr" target="#b14">6</ref> conducted a comprehensive genetic association study in 163 clozapine-induced neutropenia cases (98 with ANC o500 mm − 3 , 61 with 500⩽ ANC ⩽ 1000 mm − 3 and 4 with ANC ⩽ 1500 mm − 3 ).</s><s>The CIAC study included the following: GWAS (161 cases with clozapine-induced neutropenia, 249 clozapineexposed controls without neutropenia and 947 unexposed controls), exome array analysis (148 cases and up to 7970 unexposed controls) and classical HLA allele imputation (162 cases and 4319 unexposed controls).</s><s>These data sets formed the replication samples for the current study and were combined with results for both (i) clozapine-associated neutropenia and (ii) neutropenia ⩽ 1000 analyses.</s><s>SNPs that were associated with clozapineassociated neutropenia at Po1 × 10 − 4 from our GWAS, or Po0.05 from our HLA variant analysis, were combined with the replication data in fixedeffects meta-analyses using PLINK to estimate a combined odds ratio (OR) weighted by the study's inverse standard error (s.e.).</s><s>If an index SNP was not present in the replication data, a proxy SNP in strong LD (r 2 ⩾ 0.8) was substituted and the s.e.</s><s>weighted (s.e.w.) to account for the lack of information: s.e.w.</s><s>= s.e./sqrt(r 2 ). <ref type="bibr" target="#b29">21</ref></s><s>The variants that were associated with clozapine-associated neutropenia from exome array analyses with Po0.01 were combined with the replication data in a P-value-based method in METAL, <ref type="bibr" target="#b30">22</ref> weighted by the square root of the total sample size.</s><s>We used different P-value replication thresholds for the HLA and exome array to arrive at approximately the same number of variants.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Figure <ref type="figure" target="#fig_0">1</ref> provides a summary of the study design and key results from each analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genome-wide association study</head><p><s>We performed a GWAS of 7 559 010 genotyped and imputed common SNPs (QQ plot in Supplementary Figure <ref type="figure">5</ref>, λ GC = 0.95).</s><s>Two SNPs were associated with clozapine-associated neutropenia at the genome-wide significant level of P o 5 × 10 − 8 (Supplementary Figure <ref type="figure">6</ref> and Supplementary Data 1); rs80208670 on chromosome 13 (OR = 8.76, 95% confidence interval (CI): 4.21-18.25,</s><s>P = 6.51 × 10 − 9 ) and rs77897117 on chromosome 1 (OR = 4.02, 95% CI: 2.46-6.57,</s><s>P = 4.60 × 10 − 8 ).</s><s>Our sample size had 80% power to detect an OR44 for alleles with MAF40.10 at P o 5 × 10 − 8 (Supplementary Figure <ref type="figure">7</ref>).</s><s>The genome-wide significant SNPs from the discovery CLOZUK GWAS, rs80208670 and rs77897117, were not significantly associated in CIAC (OR = 1.69,</s><s>P = 0.27 and OR = 0.67, P = 0.28, respectively).</s></p><p><s>In total, there were 266 independent (r 2 o 0.1) SNPs associated with clozapine-associated neutropenia at Po 1 × 10 − 4 and we sought replication of these SNPs in the CIAC sample (257 of these SNPs were available or had an appropriate proxy, Supplementary Data 1).</s><s>Table 1 lists the 10 most strongly associated SNPs from the meta-analysis.</s><s>One SNP on chromosome 12 surpassed the GWS threshold for association with clozapine-associated neutropenia (OR = 4.32, P = 1.79 × 10 − 8 ).</s><s>rs149104283 is intronic to transcripts of SLCO1B3 and SLCO1B7 (solute carrier organic anion transporter family, member 1B3 and member 1B7) and was present in 7.37% of cases versus 1.52% of controls in our sample and 4.20% of cases versus 1.67% of controls in the CIAC sample.</s><s>For consideration of how this may be translated to risk allele carrier status see Supplementary Results.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HLA analysis</head><p><s>No imputed classical HLA allele or amino-acid polymorphism was associated with clozapine-associated neutropenia at the genomewide significant level (P o 5 × 10 − 8 ) in either the discovery analysis (SNPs = 7751) or combined meta-analysis (SNPs = 102; Supplementary Data 2).</s><s>It was not possible to impute the amino-acid polymorphisms HLA-DQB1 (126Q) and HLA-B (158T) implicated in the CIAC study <ref type="bibr" target="#b14">6</ref> with sufficient quality (INFO40.8) in the discovery sample.</s></p><p><s>We additionally genotyped a previously associated variant, HLA-DQB1 6672G4C 17 (rs113332494), in 60 cases and 305 age-and sex-matched controls as it was not imputed with sufficient quality.</s><s>We found independent support for association of HLA-DQB1 6672G4C (OR = 15.6, 95% CI: 1.6-151.4,</s><s>P = 0.015), replicating previous reports of association with clozapine-induced agranulocytosis. <ref type="bibr" target="#b25">17</ref></s><s>The association strengthened when considering only those with ANC below ⩽ 1000 mm −3 (OR = 38.1,</s><s>95% CI: 3.4-430.9,</s><s>analysis.</s><s>We then took forward the associated variants from GWAS, HLA and exome array analyses to a combined meta-analysis with the Clozapine-Induced Agranulocytosis Consortium (CIAC) study.</s><s>P = 0.0079).</s><s>For the associated 'G' allele, we found three heterozygote carriers among 60 cases, and a single heterozygote in 305 controls.</s><s>Lowest neutrophil counts were available for two of the three 'G' case carriers, both of whom had a neutrophil level o1000 mm −3 (700 and 900).</s><s>The association remained after adjusting for GWAS PCAs.</s><s>For further consideration of possible population-specific effects at this locus please refer to Supplementary Results.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Exome array analysis</head><p><s>In exome array analyses, no single variant exceeded a significance threshold of P o 4.3 × 10 − 7 , corresponding to a Bonferroni correction for 115 000 variants tested, in either the discovery or combined meta-analyses (Supplementary Data 3, QQ plot given in Supplementary Figure <ref type="figure">8</ref>, λ GC = 1.11).</s><s>Table <ref type="table" target="#tab_1">2</ref> lists the 10 most strongly associated exome variants from the meta-analysis.</s><s>Of interest is rs1546308 (P = 1.10 × 10 − 6 ), a missense variant in SLCO1B7 and intronic to SLCO1B3, that is 92 kb from the SNP that emerged as the only genome-wide significant variant from GWAS meta-analysis.</s><s>rs1546308 is predicted to be benign and was present in 15.8% of cases versus 5.8% of controls in our sample and 9.3% of cases versus 5.6% of controls in the CIAC sample.</s></p><p><s>Supplementary Table <ref type="table">3</ref> displays the 10 most significantly associated genes (including the total allele count and number of variants contributing to each gene) based on the SKAT-O analysis of genes with at least two uncommon (MAFo 0.05), nonsynonymous variants from the exome array.</s><s>There was evidence of association for two genes that exceeded a threshold of P o2.5 × 10 − 6 (corresponding to a Bonferroni correction of 20 000 genes tested; <ref type="bibr" target="#b31">23</ref> QQ plot in Supplementary Figure <ref type="figure">9</ref>): UBAP2 on chromosome 9 (P = 1.02 × 10 − 7 ) and STARD9 on chromosome 15 (P = 2.85 × 10 − 7 ).</s><s>Owing to differing analytical methods used by CIAC, it was not possible to combine our gene-based results in a joint analysis (see Supplementary Methods for detailed explanation).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Copy-number variation</head><p><s>In a genome-wide analysis, no individual gene was significantly enriched for large, rare exonic CNVs that exceeded a significance threshold of P o 2.5 × 10 − 6 (Supplementary Data 4).</s></p><p><s>Associations with rs1546308 and rs149104283 are not independent We investigated the independence of rs1546308 (missense variant in SLCO1B7 and intronic in SLCO1B3 from exome chip analysis) and rs149104283 (GWAS intronic variant in SLCO1B3 and SLCO1B7) in samples with data available for both variants (55 cases and 4834 controls).</s><s>The LD between the two variants in the sample was r 2 = 0.15, D' = 0.84.</s><s>In a conditional logistic regression, the strength of the association of rs1546308 with clozapine-associated  neutropenia was attenuated from OR = 3.00 (95% CI: 1.735-5.189,</s><s>P = 8.40 × 10 − 5 ) to OR = 2.16 (95% CI: 1.093-4.251,</s><s>P = 0.027) after adjusting for rs149104283.</s><s>Haplotype analysis did not strengthen the association signal.</s><s>Thus, these two findings are not independent, and the associated region spans SLCO1B1, SLCO1B3 and SLCO1B7 (Figure <ref type="figure" target="#fig_2">2</ref> and Supplementary Figure <ref type="figure" target="#fig_1">14</ref>).</s></p><p><s>Secondary analysis of clozapine-associated neutropenia below ⩽ 1000 mm −3 Results of the GWAS for the more stringent neutropenia cutoff of ⩽ 1000 mm −3 are presented in Supplementary Results.</s><s>The combined GWAS meta-analysis identified no loci exceeding genome-wide significance.</s><s>The genome-wide significant SNP from the GWAS meta-analysis, rs149104283, had a MAF of 7.8% in cases with ANC ⩽ 1000 mm − 3 , and was associated at OR = 7.6, P = 0.0027 in the discovery sample.</s><s>No variants exceeded relevant significance thresholds in imputed HLA and exome array discovery or combined meta-analyses (see Supplementary Results).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>We have conducted a multifaceted genetic analysis of clozapineassociated neutropenia in the largest combined sample studied to date.</s><s>Using GWAS, we identify a novel association implicating a family of organic anion transporters involved in drug metabolism, which have been previously associated with adverse drug reactions.</s><s>We also found evidence for effects of uncommon nonsynonymous variants within UBAP2 and STARD9 and provide independent replication of a previously identified variant in HLA-DQB1.</s><s>The primary GWAS finding from the meta-analysis was a genome-wide significant association with neutropenia for rs149104283.</s><s>The association effect size of this polymorphism is larger in the CLOZUK discovery sample (OR = 6.2) than in the CIAC replication data set (OR = 2.95), as would be expected from winner's curse.</s><s>It follows that the true effect size probably lies closer to the CIAC estimate, although this requires confirmation using independent data.</s><s>rs149104283 is an intronic SNP for transcripts of both SLCO1B3 and SLCO1B7-the associated region containing a third member of this organic anion transporter family, SLCO1B1.</s><s>SLCO1B7 encodes a putative protein (OAT1B7) that is poorly characterised, based on coding sequence prediction, and its functionality is unknown.</s><s>SLCO1B3 and SLCO1B1 share sequence homology and encode liver-specific organic anion transporter polypeptides (OATP1B3 and OATP1B1) that are multipass transmembrane proteins expressed exclusively in the basolateral membrane of hepatocytes. <ref type="bibr" target="#b32">24</ref></s><s>They facilitate uptake of exogenous substances, including drugs, from the portal vein into hepatocytes, where the substance is subsequently modified either via metabolism with cytochrome (CYP) 450 enzymes or excreted. <ref type="bibr" target="#b33">25</ref></s><s>olymorphisms in SLCO1B1 and SLCO1B3 have been implicated in adverse reactions with other drugs.</s><s>In 2008, a GWAS identified a missense variant rs4149056 in SLCO1B1 that increased the risk of simvastatin-induced myopathy by increasing the area under the curve for simvastatin, particularly in those taking high doses. <ref type="bibr" target="#b34">26</ref></s><s>This prominent pharmacogenetic finding has been widely replicated and has led to recommendations for its use as a routine preemptive clinical test. <ref type="bibr" target="#b35">27</ref></s><s>0]<ref type="bibr" target="#b39">[31]</ref> These polymorphisms were not in high LD (r 2 o 0.1 for both) with the index SNP in this study, although rs11045585 was weakly associated with neutropenia in our discovery sample (OR = 1.62,</s><s>P = 0.03).</s></p><p><s>Together, the findings suggest the hypothesis that genetic variants at SLCO1B3 (and/or SLCO1B1) increase the risk of clozapine-associated neutropenia through a pharmacokinetic mechanism.</s><s>3]<ref type="bibr" target="#b42">[34]</ref> One of the best-supported hypotheses to explain clozapine's association with agranulocytosis relates to the bioactivation of clozapine, or a stable metabolite, to a chemically reactive nitrenium ion. <ref type="bibr" target="#b43">35</ref></s><s>The propensity for nitrenium ions to cause apoptosis to neutrophils, or be toxic to neutrophil precursors, is dose-dependent, lending support to the hypothesis that clozapine pharmacokinetics and bioavailability are related to its potential to cause neutropenia. <ref type="bibr" target="#b44">36,</ref><ref type="bibr" target="#b45">37</ref></s><s>n analysis of exome chip data we found evidence of association with neutropenia for uncommon non-synonymous variants in STARD9 and UBAP2.</s><s>STARD9 is a mitotic kinesin, and STARD9depleted cancer cells have abnormal cellular morphology and undergo apoptosis. <ref type="bibr" target="#b46">38</ref></s><s>In addition, STARD9 depletion was found to synergise with the chemotherapeutic agent taxol, the use of which is dose-limited because of neutropenia. <ref type="bibr" target="#b46">38</ref></s><s>The function of UBAP2 is undetermined, although it has an ubiquitin-associated domain and is widely expressed across tissues including bone marrow.</s><s>The ubiquitination pathway has been shown to modulate the granulocyte colony-stimulating factor receptor, <ref type="bibr" target="#b47">39,</ref><ref type="bibr" target="#b48">40</ref> a critical regulator of neutrophil production.</s><s>A recent study reported the association of a missense variant in the ubiquitin gene USP43 with clozapine-associated neutropenia. <ref type="bibr" target="#b18">10</ref></s><s>ur final finding adds to the growing evidence implicating HLA-DQB1 in clozapine-associated neutropenia, supporting the recently published CIAC study. <ref type="bibr" target="#b14">6</ref></s><s>There have been further reports implicating SNPs within HLA-DQB1, <ref type="bibr" target="#b25">17,</ref><ref type="bibr" target="#b49">41,</ref><ref type="bibr" target="#b50">42</ref> although these samples and those in CIAC are overlapping; thus, we believe we provide the first fully independent replication implicating this locus in clozapine-associated neutropenia/agranulocytosis.</s><s>The HLA-DQB1 variant alone has a positive predictive value of 35.1% (see Supplementary Table <ref type="table">4</ref>).</s><s>Although this is promising, the majority of those that develop neutropenia or agranulocytosis while taking clozapine are not carriers of this risk allele, or indeed the other alleles we have identified in this study.</s><s>The sensitivity for a test including rs149104283 (GWS intronic variant in SLCO1B3 and SLCO1B7), rs1546308 (missense variant in SLCO1B7) and rs113332494 (HLA-DQB1) is 29.17%, the specificity 90.61%, the positive predictive value 9.94% and the negative predictive value 97.30% (Supplementary Table <ref type="table">4</ref>).</s><s>Although the variants identified in this study convey a substantially increased risk for clozapineassociated neutropenia, they are currently on their own unlikely to have clinical utility for pharmacogenetic testing, <ref type="bibr" target="#b51">43</ref> particularly as there is currently no alternative treatment for those with treatment-resistant schizophrenia.</s></p><p><s>An important consideration is that the majority of cases in our analyses had developed neutropenia rather than agranulocytosis.</s><s>It is now very rare in the United Kingdom to develop agranulocytosis because of the success of the monitoring system and the fact that clozapine is stopped once neutropenia is detected; in fact, only four cases met this threshold in our sample.</s><s>Despite this, we found that the major findings from our neutropenia analysis extended to the secondary analyses, which was restricted to those with an ANC ⩽ 1000 mm − 3 , indicating that the clozapine-associated neutropenia findings are likely to be applicable to those with severe neutropenia and agranulocytosis.</s></p><p><s>Our findings provide novel insights into putative biological processes underlying clozapine-associated neutropenia.</s><s>Furthermore, we have indicated a potential link between the pharmacokinetics of clozapine and risk of neutropenia/agranulocytosis with potentially important clinical implications.</s><s>The development of such understanding should help widen the availability of clozapine with a beneficial impact on those with treatmentresistant schizophrenia.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CLOZAPINE-INDUCED AGRANULOCYTOSIS CONSORTIUM (CIAC) MEMBERS</head><p><s>Jacqueline I Goldstein, SB; L Fredrik Jarskog, MD; Chris Hilliard, BS; Ana Alfirevic, PhD; Laramie Duncan, PhD; Denis Fourches, PhD; Hailiang Huang, PhD; Monkol Lek, PhD; Benjamin M Neale, PhD; Stephan Ripke, MD; Kevin Shianna, PhD; Jin P Szatkiewicz,</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>1 MRC</head><label>1</label><figDesc><div><p><s>Study individuals were from CLOZUK (n = 5493) and CardiffCOGS (Cognition in Schizophrenia, n = 156) samples.</s><s>All had clinical or research diagnoses of Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK; 2 Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA; 3 Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA; 4 Department of Psychiatry and Psychotherapy, Charité -Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany; 5 Medical and Population Genetics Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA; 6 Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA; 7 Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA; 8 King's College London, SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, De Crespigny Park, Denmark Hill, London, UK; 9 Discovery Neuroscience Research, Eli Lilly and Company Ltd, Lilly Research Laboratories, Erl Wood Manor, Surrey, UK; 10 Department of Psychiatry, University of Halle, Halle, Germany; 11 deCODE genetics, Sturlugata 8, Reykjavik, Iceland; 12 Department of Genetics, Harvard Medical School, Boston, MA, USA; 13 King's College London, Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, London, USA; 14 Department of Psychiatry, University of Munich, Munich, Germany; 15 Department of Genetics, University of North Carolina, Chapel Hill, NC, USA and 16 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</s><s>Correspondence: Dr JTR Walters, MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Hadyn Ellis Building, Maindy Road, Cathays, Cardiff CF24 4HQ, UK.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Study design and key results.</s><s>To investigate the association of genetic variants with clozapine-associated neutropenia, we conducted (a) a genome-wide association study (GWAS), (b) human leukocyte antigen (HLA) allele imputation and genotyped a candidate variant of interest, HLA-DQB1 6672G4C/ rs113332494, (c) exome array single variant and gene-based analysis and (d) copy-number variation (CNV) analysis.</s><s>We then took forward the associated variants from GWAS, HLA and exome array analyses to a combined meta-analysis with the Clozapine-Induced Agranulocytosis Consortium (CIAC) study.</s></p></div></figDesc><graphic coords="3,145.98,59.30,312.96,356.66" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Association of 12p12.2 with clozapine-associated neutropenia.</s><s>LocusZoom plot of the region associated with clozapine-associated neutropenia on chromosome 12p12.2 in CLOZUK (discovery) sample.</s><s>Genes within the region are shown in the lower panel, and the unbroken blue line indicated the recombination rate within the region.</s><s>Each circle represents the P-value for one SNP in the discovery sample, with the top SNP rs149104283 shown in purple and the SNPs in the region coloured depending on their degree of correlation (r 2 ) with rs149104283 (as estimated by LocusZoom on the basis of CEU HapMap haplotypes).</s></p></div></figDesc><graphic coords="5,134.36,59.30,336.02,231.59" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>GWAS meta-analysis top 10 SNPs SNP, single-nucleotide polymorphism.</s><s>Results are ordered by meta-analysis P-value.</s><s>Further details, including minor allele frequencies, are available in Supplementary Data 1.</s></p></div></figDesc><table><row><cell cols="2">CHR SNP</cell><cell>Position</cell><cell>A1</cell><cell cols="2">CLOZUK</cell><cell></cell><cell>CIAC</cell><cell>Meta-analysis</cell><cell>Nearest gene</cell><cell>Location</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>P-value</cell><cell>OR INFO</cell><cell>P-value</cell><cell>OR INFO</cell><cell>P-value</cell><cell>OR</cell></row><row><cell>12 13 1 7 10 16 17 17 1 14</cell><cell cols="8">rs149104283 21 083 862 T 4.98 × 10 − 7 6.20 0.87 3.61 × 10 − 3 2.95 0.87 1.79 × 10 − 8 4.32 SLCO1B3, SLCO1B7 Intronic, intronic rs80208670 84 438 088 C 6.51 × 10 − 9 8.76 0.83 0.2728 1.69 0.83 1.56 × 10 − 7 4.69 SLITRK1 13 kb Downstream rs184597564 82 236 406 A 2.48 × 10 − 5 4.03 0.89 4.99 × 10 − 3 2.40 0.94 8.01 × 10 − 7 3.06 ADGRL2 Intronic rs78900159 76 968 378 A 6.94 × 10 − 6 4.01 0.99 0.0247 1.97 0.98 2.02 × 10 − 6 2.79 GSAP Intronic rs16916041 63 146 547 T 7.40 × 10 − 6 2.57 1.02 0.0205 1.58 0.96 2.05 × 10 − 6 1.98 TMEM26 20 kb Downstream rs11649311 25 226 020 T 9.70 × 10 − 5 2.07 0.89 2.62 × 10 − 3 1.51 0.89 2.26 × 10 − 6 1.68 AQP8 2 kb Upstream rs117202297 53 769 035 T 8.48 × 10 − 6 6.25 0.82 0.1503 2.66 0.66 5.27 × 10 − 6 4.97 TMEM100 28 kb Downstream rs80282661 13 252 073 T 1.99 × 10 − 6 6.15 0.90 0.2632 1.85 0.89 5.49 × 10 − 6 4.17 HS3ST3A1 147 kb Downstream rs185053659 60 704 250 A 7.76 × 10 − 6 5.80 0.86 0.1012 2.13 0.92 8.05 × 10 − 6 3.80 C1orf87 165 kb Upstream rs78074145 40 404 458 C 1.13 × 10 − 6 4.05 0.96 0.2716 1.44 0.99 1.08 × 10 − 5 2.60 FXB033 503 kb Upstream</cell></row><row><cell cols="9">Abbreviations: A1, minor reference allele; CHR, chromosome; CIAC, Clozapine-Induced Agranulocytosis Consortium; GWAS, genome-wide association study;</cell></row><row><cell cols="2">OR, odds ratio;</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Exome array meta-analysis top 10 variants</s></p></div></figDesc><table><row><cell cols="2">CHR Variant</cell><cell>rs ID</cell><cell>Position</cell><cell>A1</cell><cell>CLOZUK</cell><cell>CIAC P-value</cell><cell>Meta-analysis</cell><cell>Gene</cell><cell>Location</cell><cell>Function</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>P-value</cell><cell></cell><cell>P-value</cell><cell></cell><cell></cell></row><row><cell>4</cell><cell>exm387558</cell><cell cols="2">rs201099591 7 436 363</cell><cell>A</cell><cell>2.48 × 10 − 3</cell><cell>1.31 × 10 − 4</cell><cell>1.10 × 10 − 6</cell><cell>PSAPL1,</cell><cell>Exonic,</cell><cell>Missense a</cell></row><row><cell>7 8 19 12</cell><cell>exm622984 exm729894 exm1421170 exm988839</cell><cell cols="3">rs17139320 63 726 370 G rs201071539 145 003 862 A rs2591594 9 076 728 A rs1546308 21 176 135 C</cell><cell>3.96 × 10 − 3 2.19 × 10 − 3 4.66 × 10 − 3 1.25 × 10 − 4</cell><cell>2.87 × 10 − 4 1.69 × 10 − 3 3.26 × 10 − 3 0.0679</cell><cell>3.70 × 10 − 6 1.19 × 10 − 5 4.52 × 10 − 5 9.13 × 10 − 5</cell><cell>SORCS2 ZNF679 PLEC MUC16 SLCO1B7,</cell><cell>intronic Exonic Exonic Exonic Exonic,</cell><cell>Missense a Missense a Missense b Missense a</cell></row><row><cell>1 15 12 12</cell><cell>exm23767 exm1186658 exm981950 exm995289</cell><cell cols="3">rs12073549 17 720 545 T rs117116488 89 390 513 T rs79149293 8 975 873 G rs138912646 42 711 606 A</cell><cell>1.60 × 10 − 3 2.76 × 10 − 4 5.66 × 10 − 5 3.94 × 10 − 5</cell><cell>0.0163 0.0448 0.0967 0.1613</cell><cell>9.31 × 10 − 5 9.73 × 10 − 5 1.01 × 10 − 4 1.79 × 10 − 4</cell><cell>SLCO1B3 PADI6 ACAN A2ML1 ZCRB1,</cell><cell>intronic Exonic Exonic Exonic Exonic,</cell><cell>Synonymous Missense b Missense c Missense a</cell></row><row><cell>12</cell><cell>exm1051374</cell><cell cols="3">rs143584336 130 921 539 A</cell><cell>1.22 × 10 − 4</cell><cell>0.1144</cell><cell>2.12 × 10 − 4</cell><cell>PPHLN1 RIMBP2</cell><cell>intronic Exonic</cell><cell>Missense a</cell></row></table><note><p><s>Abbreviations: A1, minor reference allele; CHR, chromosome; CIAC, Clozapine-Induced Agranulocytosis Consortium.</s><s>Results are ordered by meta-analysis P-value.</s><s>Predicted function of non-synonymous variants.</s><s>a Benign.</s><s>b Possibly damaging.</s><s>c Probably damaging.</s><s>Further details, including minor allele frequencies, are available in Supplementary Data 3.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Molecular Psychiatry (2017), 1502 -1508</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">© The Author(s) 2017Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>We thank the participants, clinicians, field team and MRCCNGG lab staff for their help with the CardiffCOGS study.</s><s>For the CLOZUK sample we thank Novartis for their guidance and cooperation.</s><s>We also thank staff at The Doctor's Laboratory.</s><s>This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no.</s><s>279227.</s><s>This publication reflects only the authors' views and the European Union is not liable for any use that may be made of the information contained therein.</s><s>This work was supported by a Medical Research Council (MRC) PhD studentship to SL.</s><s>The work at Cardiff University was funded by Medical Research Council (MRC) Centre (ML/L010305/1) and Program Grants (G0800509).</s><s>The schizophrenia samples were genotyped at the Broad Institute, USA, and funded by a philanthropic gift to the Stanley Centre for Psychiatric Research.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONFLICT OF INTEREST</head><p><s>LFJ has received research grant support from Teva/Auspex Pharmaceuticals and has served on a Data Safety and Monitoring Board for Janssen.</s><s>DAC is a full-time employee and stockholder of Eli Lilly and Company.</s><s>The remaining authors declare no conflicts of interest.</s><s>This work is licensed under a Creative Commons Attribution 4.0 International License.</s><s>The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material.</s><s>To view a copy of this license, visit http://creativecommons.org/licenses/ by/4.0/</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Alexander</forename><surname>Tropsha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jcg</forename><surname>Edwin</surname></persName>
		</author>
		<author>
			<persName><surname>Van Den Oord</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Ingolf</forename><surname>Cascorbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Michael</forename><surname>Md</surname></persName>
		</author>
		<author>
			<persName><surname>Dettling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd</forename><surname>Md</surname></persName>
		</author>
		<imprint>
			<pubPlace>Ephraim Gazit, MD, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Donald</surname></persName>
		</author>
		<author>
			<persName><surname>Goff</surname></persName>
		</author>
		<imprint>
			<pubPlace>MD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Mba; Deanna L</forename><surname>Arthur L Holden</surname></persName>
		</author>
		<author>
			<persName><surname>Kelly</surname></persName>
		</author>
		<imprint>
			<pubPlace>PharmD, BCPP</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">K</forename><surname>Anil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md; Jimmi</forename><surname>Malhotra</surname></persName>
		</author>
		<author>
			<persName><surname>Nielsen</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Munir</forename><surname>Pirmohamed</surname></persName>
		</author>
		<author>
			<persName><surname>Md</surname></persName>
		</author>
		<author>
			<persName><surname>Phd; Dan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Rujescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Phd; Thomas</forename><surname>Werge</surname></persName>
		</author>
		<imprint>
			<pubPlace>MSc, PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Deborah</surname></persName>
		</author>
		<author>
			<persName><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Richard</surname></persName>
		</author>
		<author>
			<persName><surname>Josiassen</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">;</forename><surname>Phd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Jeffrey A Lieberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mark</surname></persName>
		</author>
		<author>
			<persName><surname>Daly</surname></persName>
		</author>
		<imprint>
			<pubPlace>PhD</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">F</forename><surname>Patrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Franzcp</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Honigfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Meltzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="789" to="796" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Leucht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Corves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Arbter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page" from="31" to="41" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m">Report of the National Audit of Schizophrenia (NAS) 2012. Healthcare Quality Improvement Partnership</title>
				<meeting><address><addrLine>London</addrLine></address></meeting>
		<imprint>
			<publisher>Royal College of Psychiatrists</publisher>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland</title>
		<author>
			<persName><forename type="first">K</forename><surname>Atkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kendall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gould</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="483" to="488" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Clinician hesitation prior to clozapine initiation: is it justifiable?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">X</forename><surname>Patel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="425" to="427" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fredrik</forename><surname>Jarskog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hilliard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alfirevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Duncan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fourches</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">4757</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci</title>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">511</biblScope>
			<biblScope unit="page" from="421" to="427" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Analysis of copy number variations at 15 schizophrenia-associated loci</title>
		<author>
			<persName><forename type="first">E</forename><surname>Rees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Walters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Georgieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Isles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Chambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Richards</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="108" to="114" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Walters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kirov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>O'donovan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Owen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med Genet B Neuropsychiatr Genet</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="844" to="849" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Tiwari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Need</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Lohoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Zai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">I</forename><surname>Chowdhury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Muller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="403" to="405" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">A flexible and accurate genotype imputation method for the next generation of genome-wide association studies</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Howie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Donnelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Marchini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">e1000529</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Principal components analysis corrects for stratification in genome-wide association studies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Plenge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Weinblatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Shadick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Reich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="904" to="909" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">PLINK: a tool set for whole-genome association and population-based linkage analyses</title>
		<author>
			<persName><forename type="first">S</forename><surname>Purcell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Neale</forename><forename type="middle">B</forename><surname>Todd-Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="559" to="575" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">SG-ADVISER CNV: copynumber variant annotation and interpretation</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Erikson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Deshpande</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Kesavan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Torkamani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="714" to="718" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Imputing amino acid polymorphisms in human leukocyte antigens</title>
		<author>
			<persName><forename type="first">X</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Onengut-Gumuscu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Concannon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Rich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e64683</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Rapid and accurate haplotype phasing and missingdata inference for whole-genome association studies by use of localized haplotype clustering</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Browning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Browning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1084" to="1097" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Athanasiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dettling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cascorbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mosyagin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Salisbury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Pierz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="458" to="463" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A novel endonuclease IV post-PCR genotyping system</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Kutyavin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Milesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Belousov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Podyminogin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vorobiev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gorn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page">e128</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Exome arrays capture polygenic rare variant contributions to schizophrenia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Leonenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Walters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Kavanagh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Rees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Evans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1001" to="1007" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Optimal unified approach for rare-variant association testing with application to smallsample case-control whole-exome sequencing studies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Emond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Bamshad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rieder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Nickerson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="224" to="237" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder casecontrol sample</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamshere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Forty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gordon-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Russell</forename><forename type="middle">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1302" to="1307" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">METAL: fast and efficient meta-analysis of genomewide association scans</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Willer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2190" to="2191" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Guidelines for investigating causality of sequence variants in human disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Macarthur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Manolio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Dimmock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Rehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shendure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">508</biblScope>
			<biblScope unit="page" from="469" to="476" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide</title>
		<author>
			<persName><forename type="first">J</forename><surname>Konig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Nies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Keppler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="23161" to="23168" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Membrane transporters in drug development</title>
		<author>
			<persName><surname>International Transporter Consortium</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Giacomini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Tweedie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Z</forename><surname>Benet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Brouwer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Drug Discov</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="215" to="236" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">SLCO1B1 variants and statin-induced myopathy--a genomewide study</title>
		<author>
			<persName><surname>Search Collaborative Group</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Link</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Parish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Armitage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bowman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">359</biblScope>
			<biblScope unit="page" from="789" to="799" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Caudle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Haidar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Voora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Wilke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="423" to="428" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kiyotani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mushiroda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kubo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zembutsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sugiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakamura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Sci</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="967" to="972" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia</title>
		<author>
			<persName><forename type="first">T</forename><surname>Nambu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yuki</forename><forename type="middle">M</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mitsuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Pharm Bull</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="114" to="119" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yuki</forename><forename type="middle">M</forename><surname>Hirayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ther Drug Monit</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="244" to="250" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Chew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sandanaraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Lim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Clin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="606" to="618" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Cola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Meltzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="45" to="47" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites</title>
		<author>
			<persName><forename type="first">F</forename><surname>Centorrino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Baldessarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Flood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Kando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Frankenburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="610" to="612" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Clozapine metabolism rate as a possible index of drug-induced granulocytopenia</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Mauri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rudelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bravin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gianetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giuliani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guerrini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="341" to="344" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Mechanism of clozapine-induced agranulocytosis: current status of research and implications for drug development</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pirmohamed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CNS Drugs</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="139" to="158" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pirmohamed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Naisbitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Uetrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="207" to="216" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dean</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Pharmacol</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="783" to="793" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The STARD9/ Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assembly</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Summers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Brauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Senese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="1309" to="1323" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Role of the proteasome in modulating native G-CSFR expression</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Kindwall-Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Druhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ai</forename><forename type="middle">J</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Massullo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Loveland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytokine</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="114" to="123" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Druhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Loveland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Avalos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e3422</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">HLA associations in clozapine-induced agranulocytosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Yunis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Corzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Salazar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Lieberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Yunis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="1177" to="1183" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dettling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Schaub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mueller-Oerlinghausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Roots</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cascorbi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacogenetics</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="135" to="141" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Verbelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Collier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Maccabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Lewis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacogenomics J</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="461" to="466" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
